famotidine
famotidine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: famotidine; Generic name: FAMOTIDINE; Drug class: Histamine-2 Receptor Antagonist [EPC].
| Brand name | famotidine |
|---|---|
| Generic name | FAMOTIDINE |
| Drug class | Histamine-2 Receptor Antagonist [EPC] |
| Manufacturer | Navinta LLC |
| Used for | 1 INDICATIONS AND USAGE Famotidine for oral suspension is indicated in adults for the treatment of: active duodenal ulcer (DU). active gastric ulcer (GU). symptomatic nonerosive gastroesophageal reflux disease (GERD). erosive esophagitis due to GERD, diagnosed by biopsy. treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). reduction of the risk of duodenal ulcer recurrence. Famotidine for oral suspension is indicated in pediatric patients 1 year of age and older for the treatment of: peptic ulcer disease. GERD with or without esophagitis and ulcerations. Famotidine for oral suspension is indicated in pediatric patients from bi |
| Dosage | 2 DOSAGE AND ADMINISTRATION Recommended adult dosage by indication (2.1): Active DU 40 mg once daily; or 20 mg twice daily Active GU 40 mg once daily Symptomatic Nonerosive GERD 20 mg twice daily Erosive Esophagitis due to GERD 20 mg twice daily; or 40 mg twice daily Pathological Hypersecretory Conditions 20 mg every 6 hours; adjust to patient needs; maximum 160 mg every 6 hours Risk Reduction of DU Recurrence 20 mg once daily Recommended pediatric dosage by indication (2.2): Peptic Ulcer Diseas |
| Active ingredient(s) | FAMOTIDINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f34a3be-7554-4040-b808-5ba8bf064abc |